Delivery Order SPE2DB22D3501-SPE2DB24FWR30
Award Date
8/16/24
Potential Completion Date
8/19/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of OMNIPAQUE 300 MG/ML INFU BTL 100ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,171.23 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 11, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 15, 2024. There is no set-aside designation mentioned in the information...
This federal contract award is a delivery order valued at $1,200.00 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 240 MG/ML VIAL 10ML, a pharmaceutical product, with a performance period through May 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of OMNIPAQUE 300 MG/ML PLUSPAK 500ML pharmaceuticals to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,902.70 and is a firm fixed price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. This contract is not a set-aside and was awarded on May 27, 2025, with an ultimate...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of OMNIPAQUE 180 MG/ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $1,332.36 and a performance period ending on June 23, 2025. The contract is a firm-fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp...
This federal contract award, valued at $1,171.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 300 MG/ML INFU BTL 100ML, a medical product, with a completion date of February 12, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,866.06 firm-fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product. The contract has an ultimate completion date of May 12, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 150ML, a pharmaceutical product, with a ceiling value of $1,123.38. The contract is non-set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $1,071.52 and an Ultimate Completion Date of June 16, 2025. The contract is for the supply of OMNIPAQUE 350 MG/ML INFU BTL 150ML, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, is for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 100ML to the Defense Logistics Agency (DLA). The award, valued at $2,645.60, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide OMNIPAQUE 300 MG/ML PLUSPAK 500ML. The contract is a firm-fixed-price contract with a ceiling value of $1,522.16 and a period of performance through June 26, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...